My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Item 51 - Approve Proposed Community Workforce Agreement
Clerk
>
Agenda Packets / Staff Reports
>
City Council (2004 - Present)
>
2023
>
06/06/2023 Regular & HA
>
Item 51 - Approve Proposed Community Workforce Agreement
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/10/2023 2:40:41 PM
Creation date
8/10/2023 2:40:26 PM
Metadata
Fields
Template:
City Clerk
Doc Type
Agenda Packet
Agency
Clerk of the Council
Item #
51
Date
6/6/2023
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
49
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br />Community Workforce Agreement 44 City of Santa Ana <br />DRUG ABUSE PREVENTION AND DETECTION <br /> <br />APPENDIX A <br /> <br />CUTOFF LEVELS <br /> <br /> SCREENING SCREENING CONFIRMATION CONFIRMATION <br />DRUG METHOD LEVEL ** METHOD LEVEL <br /> <br />Alcohol EMIT 0.02% CG/MS 0.02% <br />Amphetamines EMIT 1000 ng/m* CG/MS 500 ng/ml* <br />Barbiturates EMIT 300 ng/ml CG/MS 200 ng/ml <br />Benzodiazepines EMIT 300 ng/ml CG/MS 300 ng/ml <br />Cocaine EMIT 300 ng/ml* CG/MS 150 ng/ml* <br />Methadone EMIT 300 ng/ml CG/MS 100 ng/ml <br />Methaqualone EMIT 300 ng/ml CG/MS 300 ng/ml <br />Opiates EMIT 2000 ng/ml* CG/MS 2000 ng/ml* <br />PCP (Phencyclidine) EMIT 25 ng/ml* CG/MS 25 ng/ml* <br />THC (Marijuana) EMIT 50 ng/ml* CG/MS 15 ng/ml* <br />Propoxyphene EMIT 300 ng/ml CG/MS 100 ng/ml <br /> <br />* SAMHSA specified threshold <br /> <br />** A sample reported positive contains the Indicated drug at or above the cutoff level for <br />that drug. A negative sample either contains no drug or contains a drug below the cutoff level. <br /> <br />EMIT - Enzyme Immunoassay <br />CC/MS - Gas Chromatography/Mass Spectrometry <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.